
- Disease
- Region
- Industry
- Agriculture
- Automotive
- Biotech/Pharmaceutical
- Chemical Manufacturing
- Computer/IT/Telecom
- Construction/Machinery
- Consulting
- Consumer Products
- Energy (Oil, Gas & Electric)
- Financial/Bank/Insurance
- Food & Beverages
- Healthcare/Medical
- Hotel/Travel/Tourism
- Industrial Manufacturing
- Legal Services
- Media/Entertainment
- Metals & Mining
- Non-corporate
- Other Industries
- Public Relations
- Transportation Services
- Intervention Type
Tools
Outstanding Business Action to Stop Tuberculosis: How Companies Contribute to the Global Fight
Report Type: Case Studies Publication
There is increasing recognition that business can play a powerful role in stopping TB. Indeed, many companies already are: a 2008 survey of 83 Global Business Coalition on HIV/AIDS, TB & Malaria (GBC) members revealed that 40 percent of respondents offer workplace information and education on TB. These companies understand the economic costs of having employees affected by TB and are responding in accordance with global public health standards and in collaboration with local partners.
Private sector engagement can extend beyond just the workplace. Companies are also active in developing and implementing community education and prevention programs, in partnership with government and NGOs. Others are applying their fundamental business strengths-or core competencies-to increase research and development efforts to improve vaccines, diagnostics and drugs for TB. To increase advocacy and awareness of TB, some companies are innovatively contributing their marketing and communication skills to the fight.
Outstanding Business Action to Stop Tuberculosis: How Companies Contribute to the Global Fight highlights eight company efforts addressing the global TB epidemic. The featured companies belong to a broad range of industries, including extractives, pharmaceuticals and public relations. This diversity illustrates the fact that every company, regardless of industry, has a potential role to play in addressing TB. Though the type of intervention, scale and outcomes of each program may vary, all of them share the following elements:
- Corporate commitment to stopping TB
- Initial focus on risk assessment/problem identification
- Integrated approach to managing TB with HIV, malaria and other diseases
- Partnerships with TB stakeholders, including governments, NGOs and technical agencies
» Give Feedback on this Report
The CDC chose Outstanding Business Action to Stop Tuberculosis: How Companies Contribute to the Global Fight to be the TB Highlight of the Month for its November, 2009 TB Training and Education Resources E-Newsletter. View other TB resources highlighted by the CDC by visiting www.findtbresources.org.
» Download Outstanding Business Action to Stop Tuberculosis: How Companies Contribute to the Global Fight
Related Topics
Disease
Intervention Type
Member Profiles
Business Action Magazine
Events
- Jun. 1 - 2, 20112011 Conference and Awards Dinner
- Oct. 31, 2011South Africa: Rural and Urban Business Action on Health
- Sep. 10, 20102nd Wellness at Work members’ Workshop
Event Takeaways
E-Learning Modules
Expert Advice
- Booz & Company's Jake Melville: Ten Recommendations: How to Make Health a Priority in the Oil & Gas Industry
- Booz & Company's Charley Beever: Funding Small Initiatives, Keeping Business a Key Partner
- Booz & Company's Jake Melville: Standardizing Health Programs and Contractual Language within an Industry




